Anesth Analg:先天性心脏病手术患气管管插管径路实行状况的研究: 鼻管插管径路对围术期结局的影响-胸外科医师协会先天性心脏病麻醉学分会数据库分析

2018-10-30 张倩 “罂粟花”微信号

虽然接受鼻插管的年感染风险增加的趋势与成年相似,但新生儿和婴儿的插管似乎没有类似的风险。新生儿和婴儿的插管也可能与较短的插管时间相关,但不会缩短住院时间。需要进行前瞻性研究以更好地了解这些复杂的相关内容。

背景与目的

在接受体外循环手术的成长中,因可以降低窦炎和感染的风险,经口腔插管通常优于经鼻插管。在儿童中,鼻插管更常见,有时更受青睐,因为需要的术后镇静剂量较少,意外拔管的风险较低。本研究旨在描述在接受体外循环手术的科群中进体外插管的情况,并比较鼻腔与口腔途径的风险/益处。

方  法

2010年12015年12月期间在胸外科学会先天性心脏病手术数据库中,包括<18岁的患者在内。排除术前气管插管,气管切开术或已知气道异常的患者。多变量建模用于评估气管插管途径与感染风险(伤口感染,纵隔炎,败血症,肺炎和心内膜炎)的综合测量之间的关联。包括协变量以调整重要的患者特征(例如体重、年龄、合并症),病例复杂性和中心效应。次要结果包括插管时间、住院时间和气道并发症,包括意外拔管。williamhill asia 还对高容量中心(>100例/年)<12个月的儿童进行了亚组分析,检查感染风险在手术时如何随年龄而变化。

结  果

在新生儿手术中使用鼻插管占41%,婴儿占38%,学龄前儿童占15%,青少年占2%。鼻插管仅对新生儿的意外拔管有保护作?(P=0.02)。婴儿和新生儿的多变量分析显示,插管的鼻腔途径与复合感染有关(相对风险[RR],0.84,95%CI,0.59-1.18)与较短的住院时间有关(RR,0.992,95%CI,0.947-1.039),但与较短的插管时间相关(RR,0.929,95%CI,0.869-0.992)。对容量中的限制显示年龄和插管途径之间存在显着的相互作用,感染的风险变化发生在大约6-12个月之间(P=0.003)。

结  论

虽然接受鼻插管的年感染风险增加的趋势与成年相似,但新生儿和婴儿的插管似乎没有类似的风险。新生儿和婴儿的插管也可能与较短的插管时间相关,但不会缩短住院时间。需要进行前瞻性研究以更好地了解这些复杂的相关内容。

原始出处:

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1700086, encodeId=18371e0008667, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sun Jun 16 16:03:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633494, encodeId=52e9163349472, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Nov 05 01:03:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635089, encodeId=47f51635089cc, content=<a href='/topic/show?id=e4b210305576' target=_blank style='color:#2F92EE;'>#麻醉学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103055, encryptionId=e4b210305576, topicName=麻醉学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=612f22405513, createdName=ms3875500703114551, createdTime=Tue Mar 05 08:03:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051273, encodeId=680d20512e31e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Feb 20 02:03:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275420, encodeId=bb6b12e54201d, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369405, encodeId=0ae613694050e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
    2019-06-16 经常头晕
  2. [GetPortalCommentsPageByObjectIdResponse(id=1700086, encodeId=18371e0008667, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sun Jun 16 16:03:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633494, encodeId=52e9163349472, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Nov 05 01:03:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635089, encodeId=47f51635089cc, content=<a href='/topic/show?id=e4b210305576' target=_blank style='color:#2F92EE;'>#麻醉学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103055, encryptionId=e4b210305576, topicName=麻醉学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=612f22405513, createdName=ms3875500703114551, createdTime=Tue Mar 05 08:03:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051273, encodeId=680d20512e31e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Feb 20 02:03:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275420, encodeId=bb6b12e54201d, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369405, encodeId=0ae613694050e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
    2018-11-05 AspirantSuo
  3. [GetPortalCommentsPageByObjectIdResponse(id=1700086, encodeId=18371e0008667, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sun Jun 16 16:03:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633494, encodeId=52e9163349472, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Nov 05 01:03:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635089, encodeId=47f51635089cc, content=<a href='/topic/show?id=e4b210305576' target=_blank style='color:#2F92EE;'>#麻醉学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103055, encryptionId=e4b210305576, topicName=麻醉学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=612f22405513, createdName=ms3875500703114551, createdTime=Tue Mar 05 08:03:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051273, encodeId=680d20512e31e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Feb 20 02:03:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275420, encodeId=bb6b12e54201d, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369405, encodeId=0ae613694050e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1700086, encodeId=18371e0008667, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sun Jun 16 16:03:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633494, encodeId=52e9163349472, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Nov 05 01:03:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635089, encodeId=47f51635089cc, content=<a href='/topic/show?id=e4b210305576' target=_blank style='color:#2F92EE;'>#麻醉学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103055, encryptionId=e4b210305576, topicName=麻醉学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=612f22405513, createdName=ms3875500703114551, createdTime=Tue Mar 05 08:03:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051273, encodeId=680d20512e31e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Feb 20 02:03:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275420, encodeId=bb6b12e54201d, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369405, encodeId=0ae613694050e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1700086, encodeId=18371e0008667, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sun Jun 16 16:03:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633494, encodeId=52e9163349472, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Nov 05 01:03:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635089, encodeId=47f51635089cc, content=<a href='/topic/show?id=e4b210305576' target=_blank style='color:#2F92EE;'>#麻醉学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103055, encryptionId=e4b210305576, topicName=麻醉学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=612f22405513, createdName=ms3875500703114551, createdTime=Tue Mar 05 08:03:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051273, encodeId=680d20512e31e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Feb 20 02:03:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275420, encodeId=bb6b12e54201d, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369405, encodeId=0ae613694050e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1700086, encodeId=18371e0008667, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sun Jun 16 16:03:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633494, encodeId=52e9163349472, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Nov 05 01:03:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635089, encodeId=47f51635089cc, content=<a href='/topic/show?id=e4b210305576' target=_blank style='color:#2F92EE;'>#麻醉学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103055, encryptionId=e4b210305576, topicName=麻醉学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=612f22405513, createdName=ms3875500703114551, createdTime=Tue Mar 05 08:03:00 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051273, encodeId=680d20512e31e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Feb 20 02:03:00 CST 2019, time=2019-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275420, encodeId=bb6b12e54201d, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369405, encodeId=0ae613694050e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Thu Nov 01 10:03:00 CST 2018, time=2018-11-01, status=1, ipAttribution=)]
    2018-11-01 huirong

相关威廉亚洲官网

FDA批准高纯度鱼油新药 有助治疗心脏病和中风

据美国“侨报纽约网”报道,美国联邦食品和药物管理局(FDA)目前批准了一种高纯度超级鱼油,可用于治疗心脏病和中风。

心脏病专家看新款苹果手表:或引发焦虑和担忧

最新的苹果手表现在可以检测您心跳的潜在问题,而且这一功能已经被美国食品和药物管理局批准。苹果称其为一项重大成就。 但来自《华盛顿邮报》的报道称,一些医生表示,在苹果手表这种受欢迎的消费产品中加入心脏监测工具可能会引发不必要的焦虑和担忧。20180916075930519.jpg苹果公司大力称赞了其手表心脏追踪功能,声称该手表可以帮助人们主动管理自己的健康。苹果首席运营官杰夫威廉姆斯负责苹果手表的开

Am J Clin Nutr:铜和锌对缺血性心脏病和心肌梗死有何影响?

2018年8月,美国和中国学者在《Am J Clin Nutr》发表一项孟德尔随机研究,考察了铜和锌对缺血性心脏病(IHD)和心肌梗死的影响。

Biophys J:胆固醇水平升高或可影响心脏治疗

2018年8月23日,在线发表于《Biophys J》杂志上的一项研究表明,胆固醇水平升高会影响到钾离子进入心脏的特定离子通道,这可能对未来的心脏治疗产生影响。

高胆固醇致心脏病?医学界有不同声音

最近十几年来,胆固醇似乎成了一个贬义词,很大程度就在于大家都认为它和心脏病有关系——血管中含有过多的胆固醇会增加心脏病、中风以及其他疾病的风险。但是,根据《临床药理学专家评论》(Expert Review of Clinical Pharmacology)杂志刊登的论文,近日有17名医生组成的研究小组发现,没有证据表明高胆固醇水平会导致心脏病。研究人员警告称,他汀类抗胆固醇药物对数百万人没有保护作

Sci Rep:杜克大学研究,睡眠不规律增加心脏病风险

杜克大学医学中心学者发表在《科学报告》杂志上的一项新研究调查强调不规律就寝有损心脏健康。 研究者表示,每天规律的上床睡觉及起床对健康也是至关重要的。